News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Newsfile Corp
NEWS
IN THE PRESS
Business
Envoy Medical Appoints David R. Wells as Chief Financial Officer
August 24, 2023
·
7 min read
BioHarvest Sciences to Host Virtual Shareholder Presentation September 6, 2023
August 24, 2023
·
2 min read
American Aires Inc. Announces Filing of Q2/2023 Financial Statements and MD&A
August 24, 2023
·
5 min read
Therma Bright Provides Update on Venowave’s Permanent CPT/HCPCS Code Application Process
August 23, 2023
·
3 min read
Policy
Kiora Pharmaceuticals Granted U.S. and European Patents for Local Ocular Delivery of the KIO-100 Family of Compounds; New IP Specifically Includes Treatment of Posterior Non-Infectious Uveitis
August 23, 2023
·
4 min read
Justera Health Announces Non-Brokered Private Placement Pursuant to Listed Issuer Financing Exemption
August 22, 2023
·
5 min read
Kiora Pharmaceuticals Taps B2i Digital to Deploy Data-Driven Investor Awareness Program
August 22, 2023
·
4 min read
Drug Development
Marvel Announces Successful Completion of Toxicology Study in Preparation for Phase 1 Human Trials
August 22, 2023
·
5 min read
NervGen Pharma to Present on its Drug Candidate NVG-291 and Spinal Cord Injury at Investor Conference
August 22, 2023
·
5 min read
Deals
Skye Completes $17M Financing and Acquires Novel Phase 2-Ready CB1-Inhibiting Monoclonal Antibody
August 21, 2023
·
9 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us